Generic Name: Keytruda for Hodgkin's Lymphoma ()
Keytruda for Hodgkin's Lymphoma Reviews
"Recurrent Hodgkin lymphoma and Keytruda put me in remission immediately, first infusion. It is a miracle drug for many! However, side effects after 7 months of treatment were becoming unbearable and ceased. Skin and lung issues from first month. Been 3 months since stopping infusions and seem to be improving!"
More about Keytruda (pembrolizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (230)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Patient resources
- Keytruda drug information
Professional resources
- Keytruda prescribing information
- Pembrolizumab (AHFS Monograph)
Related treatment guides
- Breast Cancer
- Bladder Cancer
- Cervical Cancer
- Biliary Tract Tumor
